Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Susan C Modesitt & Amir A Jazaeri. (2007) Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics. Expert Opinion on Pharmacotherapy 8:14, pages 2293-2305.
Read now
Read now
Ronald J Buckanovich. (2007) Ovarian cancer vaccine trials and tribulations. Expert Opinion on Biological Therapy 7:1, pages 103-112.
Read now
Read now
Articles from other publishers (12)
L. Kapka-Skrzypczak, E. Wolinska, G. Szparecki, G.M. Wilczynski, M. Czajka & M. Skrzypczak. (2015) CD55, CD59, factor H and factor H-like 1 gene expression analysis in tumors of the ovary and corpus uteri origin. Immunology Letters 167:2, pages 67-71.
Crossref
Crossref
Cinthia V. Pastuskovas, William Mallet, Suzanna Clark, Margaret Kenrick, Mohammed Majidy, Michelle Schweiger, Marjie Van Hoy, Siao Ping Tsai, Gregory Bennett, Ben-Quan Shen, Sarajane Ross, Paul Fielder, Leslie Khawli & Jay Tibbitts. (2010) Effect of Immune Complex Formation on the Distribution of a Novel Antibody to the Ovarian Tumor Antigen CA125. Drug Metabolism and Disposition 38:12, pages 2309-2319.
Crossref
Crossref
Doris R. Siwak, Mark Carey, Bryan T. Hennessy, Catherine T. Nguyen, Mollianne J. McGahren Murray, Laura Nolden & Gordon B. Mills. (2010) Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges. Journal of Oncology 2010, pages 1-20.
Crossref
Crossref
Alberto Zacchetti, Angela Coliva, Elena Luison, Ettore Seregni, Emilio Bombardieri, Augusto Giussani, Mariangela Figini & Silvana Canevari. (2009) 177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts. Nuclear Medicine and Biology 36:7, pages 759-770.
Crossref
Crossref
Torgny Stigbrand, David Eriksson, Katrine Riklund & Lennart Johansson. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy
59
76
.
C. Andrew Boswell & Martin W. Brechbiel. (2007) Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. Nuclear Medicine and Biology 34:7, pages 757-778.
Crossref
Crossref
Sophia N. Karagiannis, Marguerite G. Bracher, James Hunt, Natalie McCloskey, Rebecca L. Beavil, Andrew J. Beavil, David J. Fear, Richard G. Thompson, Nicholas East, Frances Burke, Robert J. Moore, David D. Dombrowicz, Frances R. Balkwill & Hannah J. Gould. (2007) IgE-Antibody-Dependent Immunotherapy of Solid Tumors: Cytotoxic and Phagocytic Mechanisms of Eradication of Ovarian Cancer Cells. The Journal of Immunology 179:5, pages 2832-2843.
Crossref
Crossref
A. Poveda, R. Salazar, J. M. del Campo, C. Mendiola, J. Cassinello, B. Ojeda, J. A. Arranz, A. Oaknin, J. García-Foncillas, M. J. Rubio & A. González Martín. (2007) Update in the management of ovarian and cervical carcinoma. Clinical and Translational Oncology 9:7, pages 443-451.
Crossref
Crossref
Youjun Chen, Suzanna Clark, Terence Wong, Yongmei Chen, Yvonne Chen, Mark S. Dennis, Elizabeth Luis, Fiona Zhong, Sheila Bheddah, Hartmut Koeppen, Alvin Gogineni, Sarajane Ross, Paul Polakis & William Mallet. (2007) Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models. Cancer Research 67:10, pages 4924-4932.
Crossref
Crossref
Karin Knogler, Jürgen Grünberg, Kurt Zimmermann, Susan Cohrs, Michael Honer, Simon Ametamey, Peter Altevogt, Mina Fogel, P. August Schubiger & Ilse Novak-Hofer. (2007) Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis. Clinical Cancer Research 13:2, pages 603-611.
Crossref
Crossref
Jochen Reinsberg. 2007. Monoclonal Antibodies. Monoclonal Antibodies
195
204
.
G. Lidouren & J. Martin. (2005) Place de la chimiothérapie de première ligne dans le cancer de l’ovaire. Actualités Pharmaceutiques Hospitalières 1:4, pages 13-24.
Crossref
Crossref